Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDeliveroo Regulatory News (ROO)

Share Price Information for Deliveroo (ROO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 141.80
Bid: 141.60
Ask: 141.80
Change: -0.50 (-0.35%)
Spread: 0.20 (0.141%)
Open: 139.00
High: 142.10
Low: 139.00
Prev. Close: 142.30
ROO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EBT Share Purchase Programme

1 Sep 2022 07:00

RNS Number : 8503X
Deliveroo PLC
01 September 2022
 

1 September 2022

 

Deliveroo plc ("Deliveroo" or the "Company")

EBT Share Purchase Programme

Further to the announcement made by Deliveroo in its half-yearly financial report 2022, the Company announces that Ocorian Limited ("Ocorian" or the "Trustee"), which administers the Roofoods Ltd Employee Benefit Trust (the "EBT") will start making market purchases of Class A ordinary shares of 0.5p each in the Company ("A Shares") (the "EBT Share Purchase Programme"). The EBT Share Purchase Programme will, unless terminated by either Goldman Sachs International or the Trustee at an earlier date, expire on 28 February 2023. Shares purchased under the EBT Share Purchase Programme will be used to satisfy employee share-based compensation awards.

Under the EBT Share Purchase Programme, the Trustee will instruct Goldman Sachs International, as broker, to acquire A Shares for the EBT. Purchases under the EBT Share Purchase Programme will be limited to £75,000,000 of A Shares (by market value). Purchases under the EBT Share Purchase Programme will be carried out in compliance with the provisions of Chapter 12 of the Financial Conduct Authority's Listing Rules in respect of price and volume requirements, Article 5 of the Market Abuse Regulation No.596/2014 and Article 3 of Commission Delegated Regulation (EU) 2016/1052, which require that: (a) the maximum price paid for such A Shares shall be an amount equal to the higher of: (i) 5% above the average of the closing price of the A Shares as derived from the Primary Exchange Daily Official List for the five business days before the purchase is made; (ii) the price of the last independent trade of A Shares on the venue where the purchase is carried out; (iii) the highest current independent bid for an A Share as derived from the trading venue where the purchase is carried out; and (b) purchases of such A Shares will be limited to 25% of the average daily volume of A Shares for the last 20 days on the trading venue on which the purchases are carried out.

Ocorian, as Trustee of the EBT, can hold up to 5% of the Company's issued Class A ordinary share capital and has absolute discretion and independence in respect of all trading decisions it may make in respect of the purchase of A Shares pursuant to the EBT Share Purchase Programme.

 

Contacts

Investor relations

David Hancock, VP Investor Relations

Tim Warrington, Investor Relations Director 

investors@deliveroo.co.uk

Media relations

Joe Carberry, VP Communications

07787 561 905

Tulchan Communications, James Macey White,Jessica Reid, Mark Burgess

Deliveroo@tulchangroup.com

 

 

About Deliveroo

Deliveroo is an award-winning delivery service founded in 2013 by William Shu and Greg Orlowski. Deliveroo works with approximately 180,000 best-loved restaurants and grocery partners, as well as around 180,000 riders to provide the best food delivery experience in the world. Deliveroo is headquartered in London, with offices around the globe. Deliveroo operates across 11 markets, including Australia, Belgium, France, Hong Kong, Italy, Ireland, Netherlands, Singapore, United Arab Emirates, Kuwait and the United Kingdom. Further information regarding Deliveroo is available on the Company's website at https://corporate.deliveroo.co.uk/.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSUAVRRUSUWOUR
Date   Source Headline
20th May 202411:00 amRNSEBT Share Purchase Programme
13th May 202411:00 amRNSEBT Share Purchase Programme
7th May 202411:00 amRNSEBT Share Purchase Programme
30th Apr 202410:00 amRNSTotal Voting Rights
29th Apr 202411:00 amRNSEBT Share Purchase Programme
22nd Apr 20245:16 pmRNSDirector/PDMR Shareholding
22nd Apr 202411:00 amRNSEBT Share Purchase Programme
18th Apr 20247:00 amRNSQ1 2024 Trading Update
17th Apr 202410:00 amRNSNotice of AGM
16th Apr 20241:00 pmRNSHolding(s) in Company
15th Apr 202411:00 amRNSEBT Share Purchase Programme
12th Apr 20245:13 pmRNSHolding(s) in Company
11th Apr 202411:07 amRNSBlock listing Interim Review
10th Apr 202411:00 amRNSHolding(s) in Company
9th Apr 202411:00 amRNSHolding(s) in Company
9th Apr 202411:00 amRNSHolding(s) in Company
8th Apr 202411:00 amRNSEBT Share Purchase Programme
8th Apr 20247:05 amRNSHolding(s) in Company
8th Apr 20247:00 amRNSDirector/PDMR Shareholding
5th Apr 20247:00 amRNSConversion of B Shares, Share Redesignation & TVR
28th Mar 202411:00 amRNSTotal Voting Rights
27th Mar 20247:00 amRNSEBT Share Purchase Programme
25th Mar 20241:00 pmRNSDirector/PDMR Shareholding
21st Mar 202411:45 amRNSAnnual Financial Report
14th Mar 20247:00 amRNSDeliveroo FY2023 Preliminary Results
4th Mar 202411:00 amRNSHolding(s) in Company
29th Feb 202411:00 amRNSHolding(s) in Company
29th Feb 202410:00 amRNSTotal Voting Rights
2nd Feb 202411:45 amRNSHolding(s) in Company
2nd Feb 202411:30 amRNSHolding(s) in Company
30th Jan 20244:15 pmRNSHolding(s) in Company
22nd Jan 20243:30 pmRNSHolding(s) in Company
19th Jan 20247:00 amRNSQ4 2023 Trading Update
15th Jan 20243:00 pmRNSHolding(s) in Company
2nd Jan 202410:00 amRNSTotal Voting Rights
13th Dec 202311:00 amRNSHolding(s) in Company
4th Dec 20237:00 amRNSTransaction in Own Shares
1st Dec 202312:00 pmRNSHolding(s) in Company
1st Dec 20237:00 amRNSTransaction in Own Shares
30th Nov 202311:00 amRNSTotal Voting Rights
30th Nov 20237:00 amRNSTransaction in Own Shares
29th Nov 20237:00 amRNSCapital Markets Event
29th Nov 20237:00 amRNSTransaction in Own Shares
28th Nov 20237:00 amRNSTransaction in Own Shares
27th Nov 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSTransaction in Own Shares
10th Nov 20234:00 pmRNSHolding(s) in Company
10th Nov 20233:00 pmRNSHolding(s) in Company
8th Nov 20234:30 pmRNSHolding(s) in Company
8th Nov 20233:00 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.